Repetitive Transcranial Magnetic Stimulation in SCA3 Patients
Learn more about:
Related Clinical Trial
Treatment of Transcranial Alternating Current Stimulation(tACS)on Cerebellar Ataxia
Repetitive Transcranial Magnetic Stimulation in SCA3 Patients
STRIDES – a Clinical Research Study of an Investigational New Drug to Treat Spinocerebellar Ataxia
A Pharmacokinetics and Safety Study of BIIB132 in Adults With Spinocerebellar Ataxia 3
Neuropsychiatry and Cognition in SCA3/MJD
Astrocytic Markers and the Pre-ataxic Period of SCA3/MJD – BIGPRO Study Astrocytes
Clinical Effects of Oral Trehalose In Patients With Spinocerebellar Ataxia 3
Efficacy Of Oral Trehalose In Spinocerebellar Ataxia 3
Hong Kong Spinocerebellar Ataxias Registry
Cerebello-Spinal tDCS as Rehabilitative Intervention in Neurodegenerative Ataxia
Rehabilitative Trial With Cerebello-Spinal tDCS in Neurodegenerative Ataxia
Measuring Neurological Impairment and Functional Visual Assessment In Spinocerebellar Ataxias
Clinical Trial Readiness for SCA1 and SCA3
Natural History of Oculomotor Neurophysiology in Ataxic and Pre-ataxic Carriers of SCA3/MJD
Study to Determine the Safety and Tolerability of Varenicline (Chantix®) in Treating Spinocerebellar Ataxia Type 3
Identification of Biomarkers in Spinocerebellar Ataxia 3
Machado-Joseph Disease in Israel
Pilot Study of Safety and Efficacy of Sodium Phenylbutyrate in Spinocerebellar Ataxia Type 3
Safety and Efficacy of Lithium Carbonate in Patients With Spinocerebellar Ataxia Type 3